Extendicare (EXE) Competitors C$14.19 -0.21 (-1.46%) As of 01:05 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesBuy This Stock EXE vs. DNTL, SIA, WELL, DR, KDA, NLH, PHA, BLU, TRIL, and BHCShould you be buying Extendicare stock or one of its competitors? The main competitors of Extendicare include dentalcorp (DNTL), Sienna Senior Living (SIA), WELL Health Technologies (WELL), Medical Facilities (DR), KDA Group (KDA), Nova Leap Health (NLH), Premier Health of America (PHA), BELLUS Health (BLU), Trillium Therapeutics (TRIL), and Bausch Health Companies (BHC). These companies are all part of the "medical" sector. Extendicare vs. dentalcorp Sienna Senior Living WELL Health Technologies Medical Facilities KDA Group Nova Leap Health Premier Health of America BELLUS Health Trillium Therapeutics Bausch Health Companies dentalcorp (TSE:DNTL) and Extendicare (TSE:EXE) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, media sentiment, community ranking, valuation, earnings, analyst recommendations, institutional ownership and profitability. Do analysts rate DNTL or EXE? dentalcorp currently has a consensus target price of C$12.59, suggesting a potential upside of 45.59%. Extendicare has a consensus target price of C$12.83, suggesting a potential downside of 9.56%. Given dentalcorp's stronger consensus rating and higher possible upside, equities research analysts plainly believe dentalcorp is more favorable than Extendicare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score dentalcorp 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00Extendicare 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the MarketBeat Community believe in DNTL or EXE? Extendicare received 114 more outperform votes than dentalcorp when rated by MarketBeat users. However, 66.07% of users gave dentalcorp an outperform vote while only 47.04% of users gave Extendicare an outperform vote. CompanyUnderperformOutperformdentalcorpOutperform Votes3766.07% Underperform Votes1933.93% ExtendicareOutperform Votes15147.04% Underperform Votes17052.96% Does the media prefer DNTL or EXE? In the previous week, dentalcorp and dentalcorp both had 1 articles in the media. Extendicare's average media sentiment score of 0.92 beat dentalcorp's score of 0.51 indicating that Extendicare is being referred to more favorably in the news media. Company Overall Sentiment dentalcorp Positive Extendicare Positive Do institutionals & insiders have more ownership in DNTL or EXE? 50.3% of dentalcorp shares are owned by institutional investors. Comparatively, 19.2% of Extendicare shares are owned by institutional investors. 0.2% of dentalcorp shares are owned by company insiders. Comparatively, 13.9% of Extendicare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more volatility & risk, DNTL or EXE? dentalcorp has a beta of 1.26, meaning that its share price is 26% more volatile than the S&P 500. Comparatively, Extendicare has a beta of 1.26, meaning that its share price is 26% more volatile than the S&P 500. Is DNTL or EXE more profitable? Extendicare has a net margin of 4.48% compared to dentalcorp's net margin of -5.40%. Extendicare's return on equity of 64.13% beat dentalcorp's return on equity.Company Net Margins Return on Equity Return on Assets dentalcorp-5.40% -4.71% 0.77% Extendicare 4.48%64.13%7.16% Which has stronger earnings & valuation, DNTL or EXE? Extendicare has lower revenue, but higher earnings than dentalcorp. dentalcorp is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatiodentalcorpC$1.49B1.09-C$80.68M-C$0.43-20.11ExtendicareC$1.46B0.81C$65.46MC$0.7818.09 SummaryExtendicare beats dentalcorp on 9 of the 16 factors compared between the two stocks. Get Extendicare News Delivered to You Automatically Sign up to receive the latest news and ratings for EXE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EXE vs. The Competition Export to ExcelMetricExtendicareMedical Care Facilities IndustryMedical SectorTSE ExchangeMarket CapC$1.18BC$1.68BC$5.33BC$5.95BDividend Yield4.42%3.83%5.21%6.33%P/E Ratio18.097.2126.8530.01Price / Sales0.8112.81388.74842.45Price / Cash3.2012.5138.2583.71Price / Book10.171.976.764.00Net IncomeC$65.46MC$58.65MC$3.23BC$301.69M7 Day Performance-2.27%5.86%1.71%0.94%1 Month Performance8.74%212.30%11.16%7.63%1 Year Performance80.30%11.40%17.17%15.98% Extendicare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EXEExtendicare0.9291 of 5 starsC$14.19-1.5%C$12.83-9.6%+83.9%C$1.18BC$1.46B18.0923,000Dividend AnnouncementAnalyst ForecastDNTLdentalcorp2.6603 of 5 starsC$8.58+0.6%C$12.59+46.8%+31.6%C$1.61BC$1.49B-19.959,950Analyst ForecastSIASienna Senior Living0.542 of 5 starsC$17.93+1.9%C$18.50+3.2%+20.2%C$1.48BC$938.65M44.3912,000Analyst ForecastWELLWELL Health Technologies2.9351 of 5 starsC$4.19+1.7%C$8.08+92.7%+5.7%C$1.05BC$962.00M14.20510DRMedical Facilities0.5331 of 5 starsC$15.54+1.1%C$14.75-5.1%+29.7%C$252.83MC$388.07M10.401,833News CoverageKDAKDA GroupN/AC$0.25-2.0%N/A-34.2%C$43.85MC$28.71M-7.503,100News CoverageNLHNova Leap HealthN/AC$0.25-2.0%N/A-18.2%C$13.93MC$16.71M-30.19N/APositive NewsGap DownPHAPremier Health of America1.1378 of 5 starsC$0.09+5.9%C$0.65+622.2%-78.8%C$5.00MC$158.32M-0.40N/ANews CoverageGap DownHigh Trading VolumeBLUBELLUS HealthN/AN/AN/AN/AC$2.47BC$16,000.00-20.2974TRILTrillium TherapeuticsN/AN/AN/AN/AC$2.45BC$43,000.00-34.0633BHCBausch Health CompaniesN/AC$6.53+1.4%N/A-30.4%C$1.70BC$6.69B-9.5619,900 Related Companies and Tools Related Companies dentalcorp Alternatives Sienna Senior Living Alternatives WELL Health Technologies Alternatives Medical Facilities Alternatives KDA Group Alternatives Nova Leap Health Alternatives Premier Health of America Alternatives BELLUS Health Alternatives Trillium Therapeutics Alternatives Bausch Health Companies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:EXE) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredAI Bloodbath Coming on June 1st?If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Extendicare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Extendicare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EXE Stock Free EXE Stock Alerts